This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04787/identifier/pdb/
n13http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB04787/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB04787/identifier/pubchem-substance/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04787/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04787/identifier/chemspider/

Statements

Subject Item
n2:DB04787
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n12:DB04787 n13:DB04787
dcterms:title
Tanaproget
adms:identifier
n7:4369524 n8:46509047 n9:DB04787 n10:T98 n14:3572060
n4:synthesisReference
Arwinder Nagi, Ramarao Chatlapalli, Shamim Hasan, Mohamed Ghorab, Dhaval Gaglani, "Micronized tanaproget, compositions, and methods of preparing the same." U.S. Patent US20060246135, issued November 02, 2006.
n4:IUPAC-Name
n5:271B536B-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B5371-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B5370-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B536D-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B536E-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B536F-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B5369-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B536A-363D-11E5-9242-09173F13E4C5 n5:271B5367-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B5368-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B5377-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B5378-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B5372-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B5373-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B5375-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B5374-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B5376-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B537D-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B537F-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B5380-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B537C-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B537B-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B537E-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B536C-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5379-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B537A-363D-11E5-9242-09173F13E4C5